GSK Committed To Patient Outcomes

Dr. Jonathan Pan, Vice President, GM of Malaysia, GSK

Morning Run · The Breakfast Grille · 30 May 2022 · 08:00 am · 23 mins listen

GSK will split into two new companies in 2022, they are GSK and Haleon. So what does this spin-off mean for Malaysia and the healthcare industry? Philip See speaks to Dr. Jonathan Pan, Vice President and GM of Malaysia and Brunei at GSK about their top-selling drugs, their role in the Covid-19 pandemic, and can Malaysia be a vaccine manufacturing hub?

Produced by:

Moh Heng Ying

Presented by:

Philip See

Categories:

Corporates,managing disease,medical advances

Tags:

gsk

Related Content